Related Articles
iRGD as a tumor‑penetrating peptide for cancer therapy (Review)
Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy
Coupling Gd‑DTPA with a bispecific, recombinant protein anti‑EGFR‑iRGD complex improves tumor targeting in MRI
D‑allose enhances the efficacy of hydroxychloroquine against Lewis lung carcinoma cell growth by inducing autophagy
Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts